Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Immunotherapy of Neuromyelitis Optica.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Pregnancy and multiple sclerosis.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
Unmet Needs of Patients Feeling Severely Affected by Multiple Sclerosis in Germany: A Qualitative Study.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
PET imaging in multiple sclerosis.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Clinical data and regulatory issues of biosimilar products.
Occupational attainment as a marker of cognitive reserve in multiple sclerosis.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
Cladribine in multiple sclerosis: pitfalls in a new treatment landscape.
Vitamin d assays: past and present debates, difficulties, and developments.
Restless Legs Syndrome in Multiple Sclerosis.
Early presentation of neuromyelitis optica.
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
New treatments for multiple sclerosis: at what long-term risk?

Pages